Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Rivaroxaban in high-risk ambulatory cancer patients receiving systemic therapy

Dr Alok Khorana - Cleveland Clinic, Cleveland, USA

Rivaroxaban in high-risk ambulatory cancer patients receiving systemic therapy ( Dr Alok Khorana - Cleveland Clinic, Cleveland, USA )

Ibrutinib-based therapy superior for younger patients with previously untreated...

Dr Tait Shanafelt - Stanford University, Stanford, USA

Ibrutinib-based therapy superior for younger patients with previously untreated CLL compared with current standard of care ( Dr Tait Shanafelt - Stanford University, Stanford, USA )

Daratumumab found to increase PFS in patients with transplant-ineligible newly...

Prof Thierry Facon - Hôpital Claude Huriez, Lille, France

Daratumumab found to increase PFS in patients with transplant-ineligible newly diagnosed multiple myeloma ( Prof Thierry Facon - Hôpital Claude Huriez, Lille, France )

Patient treatment preferences in relapsed/refractory multiple myeloma

Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos

$Patient treatment preferences in relapsed/refractory multiple myeloma ( Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos )$

Landscape change with oral proteasome maintenance in multiple myeloma patients

Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar...

Landscape change with oral proteasome maintenance in multiple myeloma patients ( Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar Lonial )

The importance of NF-kB pathway in myeloma

Dr Nizar Bahlis - University of Calgary, Calgary, Canada

The importance of NF-kB pathway in myeloma ( Dr Nizar Bahlis - University of Calgary, Calgary, Canada )

Multiple myeloma highlights and more from ASH 2018

Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France

Multiple myeloma highlights and more from ASH 2018 ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )

Results of the Beat AML umbrella study for previously untreated acute myeloid...

Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA

Results of the Beat AML umbrella study for previously untreated acute myeloid leukaemia ( Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA )

An integrated view of the role of the B cell antigen receptor in lymphoma cell...

Dr Stefano Casola - Institute of Molecular Oncology Foundation, Milan, Italy

An integrated view of the role of the B cell antigen receptor in lymphoma cell fitness ( Dr Stefano Casola - Institute of Molecular Oncology Foundation, Milan, Italy )

Myeloma XI study: Quadruplet regimen for transplant eligible patients

Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK

Myeloma XI study: Quadruplet regimen for transplant eligible patients ( Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK )

Developments in CAR T treatments for adult patients

Dr David Miklos - Stanford University, Palo Alto, USA

Developments in CAR T treatments for adult patients ( Dr David Miklos - Stanford University, Palo Alto, USA )

Outcomes for patients with disease progression following CD19-specific CAR T...

Dr Victor Chow - Fred Hutchinson Cancer Research Centre, Seattle, USA

Outcomes for patients with disease progression following CD19-specific CAR T-cell therapy ( Dr Victor Chow - Fred Hutchinson Cancer Research Centre, Seattle, USA )

More from ecancer